Retacrit
Epoetin alfa-epbx · Pfizer Laboratories Div Pfizer Inc
PRESCRIPTION ONLY (USA)Retacrit ingredients
| Active ingredient | Strength |
|---|---|
| Epoetin | 2000 [iU]/mL, 10000 [iU]/mL, 20000 [iU]/mL, 40000 [iU]/mL, 3000 [iU]/mL, 4000 [iU]/mL |
What Retacrit is used for
Retacrit is a specialist medicine (erythropoiesis-stimulating agent). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Retacrit
- Generic name
- Epoetin alfa-epbx
- Made by
- Pfizer Laboratories Div Pfizer Inc
- Forms
- Injection, Solution
- Given
- Intravenous, Subcutaneous
- Drug class
- Erythropoiesis-stimulating Agent
- FDA approval
- Biologic licence (BLA) BLA125545
- On the US market since
- 2018
Official information
- Retacrit prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Epoetin alfa-epbx)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Retacrit?
Retacrit (Epoetin alfa-epbx) is a specialist medicine made by Pfizer Laboratories Div Pfizer Inc, approved by the US FDA.
What are the ingredients of Retacrit?
Retacrit contains Epoetin (2000 [iU]/mL, 10000 [iU]/mL, 20000 [iU]/mL, 40000 [iU]/mL, 3000 [iU]/mL, 4000 [iU]/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA